AI reads brain scans to spot Parkinson's early
NCT ID NCT05080296
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether artificial intelligence (AI) can help diagnose Parkinson's disease by analyzing brain scans called DaTSCAN SPECT. Researchers used machine learning to tell the difference between healthy people, those with Parkinson's, and those with similar conditions. The study looked at scans from over 1,600 patients taken between 2011 and 2017. If the AI works well, it could make diagnosis faster and more accurate.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
machine learning algorithm
What this could lead to
If successful, this AI tool could help doctors diagnose Parkinson's disease earlier and more accurately, reducing misdiagnosis.
What could go wrong
This is a completed analysis of existing scans, not a real-world test. The AI may not work as well in different hospitals or with diverse patient groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nuclear medicine department CHRU de NANCY
Vandœuvre-lès-Nancy, 54511, France